首页 › 重度抑郁症 › 得克萨斯州 › Richardson
Richardson TX 重度抑郁症临床试验
5项针对 重度抑郁症的研究正在 Richardson及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
招募中3 期
- Pillar Clinical Research, LLC, Richardson
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
招募中3 期
- Vanda Investigational Site, Richardson
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
招募中2 期
- Seaport Investigator Site, Richardson
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Richardson
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
招募中2 期
- Pillar Clinical Research - Richardson /ID# 276764, Richardson
其他城市的 重度抑郁症试验
- New York City, NY37 项研究
- Boston, MA31 项研究
- Atlanta, GA25 项研究
- Philadelphia, PA23 项研究
- Orlando, FL19 项研究
- Miami, FL18 项研究
- Chicago, IL17 项研究
- Tampa, FL17 项研究
- Houston, TX16 项研究
- San Diego, CA16 项研究
- Little Rock, AR14 项研究
- Orange, CA13 项研究
Richardson的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。